BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22446512)

  • 1. Multi-centre calibration of an adaptive thresholding method for PET-based delineation of tumour volumes in radiotherapy planning of lung cancer.
    Schaefer A; Nestle U; Kremp S; Hellwig D; Grgic A; Buchholz HG; Mischke W; Gromoll C; Dennert P; Plotkin M; Senftleben S; Thorwarth D; Tosch M; Wahl A; Wengenmair H; Rübe C; Kirsch CM
    Nuklearmedizin; 2012; 51(3):101-10. PubMed ID: 22446512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data.
    Schaefer A; Kremp S; Hellwig D; Rübe C; Kirsch CM; Nestle U
    Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):1989-99. PubMed ID: 18661128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of different contributions of scatter and attenuation on the threshold values in contrast-based algorithms for volume segmentation.
    Matheoud R; Della Monica P; Secco C; Loi G; Krengli M; Inglese E; Brambilla M
    Phys Med; 2011 Jan; 27(1):44-51. PubMed ID: 20399128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The integration of PET-CT scans from different hospitals into radiotherapy treatment planning.
    Ollers M; Bosmans G; van Baardwijk A; Dekker A; Lambin P; Teule J; Thimister W; Rhamy A; De Ruysscher D
    Radiother Oncol; 2008 Apr; 87(1):142-6. PubMed ID: 18207269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
    Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
    J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning.
    Hong R; Halama J; Bova D; Sethi A; Emami B
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):720-6. PubMed ID: 17293230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters.
    Westerterp M; Pruim J; Oyen W; Hoekstra O; Paans A; Visser E; van Lanschot J; Sloof G; Boellaard R
    Eur J Nucl Med Mol Imaging; 2007 Mar; 34(3):392-404. PubMed ID: 17033848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor delineation using PET in head and neck cancers: threshold contouring and lesion volumes.
    Ford EC; Kinahan PE; Hanlon L; Alessio A; Rajendran J; Schwartz DL; Phillips M
    Med Phys; 2006 Nov; 33(11):4280-8. PubMed ID: 17153406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of PET quantification accuracy in vivo. Comparison of measured FDG concentration in the bladder with urine samples.
    Maus J; Hofheinz F; Schramm G; Oehme L; Beuthien-Baumann B; Lukas M; Buchert R; Steinbach J; Kotzerke J; van den Hoff J
    Nuklearmedizin; 2014; 53(3):67-77. PubMed ID: 24553628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Dirichlet process mixture model for automatic (18)F-FDG PET image segmentation: Validation study on phantoms and on lung and esophageal lesions.
    Giri MG; Cavedon C; Mazzarotto R; Ferdeghini M
    Med Phys; 2016 May; 43(5):2491. PubMed ID: 27147360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET based volume segmentation with emphasis on the iterative TrueX algorithm.
    Knäusl B; Hirtl A; Dobrozemsky G; Bergmann H; Kletter K; Dudczak R; Georg D
    Z Med Phys; 2012 Feb; 22(1):29-39. PubMed ID: 21251804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining a radiotherapy target with positron emission tomography.
    Black QC; Grills IS; Kestin LL; Wong CY; Wong JW; Martinez AA; Yan D
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1272-82. PubMed ID: 15519800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Static and moving phantom studies for radiation treatment planning in a positron emission tomography and computed tomography (PET/CT) system.
    Okubo M; Nishimura Y; Nakamatsu K; Okumura M; Shibata T; Kanamori S; Hanaoka K; Hosono M
    Ann Nucl Med; 2008 Aug; 22(7):579-86. PubMed ID: 18756360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segmentation of PET volumes by iterative image thresholding.
    Jentzen W; Freudenberg L; Eising EG; Heinze M; Brandau W; Bockisch A
    J Nucl Med; 2007 Jan; 48(1):108-14. PubMed ID: 17204706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).
    Edet-Sanson A; Dubray B; Doyeux K; Back A; Hapdey S; Modzelewski R; Bohn P; Gardin I; Vera P
    Radiother Oncol; 2012 Feb; 102(2):251-7. PubMed ID: 21885145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualification of PET scanners for use in multicenter cancer clinical trials: the American College of Radiology Imaging Network experience.
    Scheuermann JS; Saffer JR; Karp JS; Levering AM; Siegel BA
    J Nucl Med; 2009 Jul; 50(7):1187-93. PubMed ID: 19525463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of PET reconstruction parameters on the TrueX algorithm. A combined phantom and patient study.
    Knäusl B; Rausch IF; Bergmann H; Dudczak R; Hirtl A; Georg D
    Nuklearmedizin; 2013; 52(1):28-35. PubMed ID: 23348719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative PET/CT scanner performance characterization based upon the society of nuclear medicine and molecular imaging clinical trials network oncology clinical simulator phantom.
    Sunderland JJ; Christian PE
    J Nucl Med; 2015 Jan; 56(1):145-52. PubMed ID: 25525180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?
    Biehl KJ; Kong FM; Dehdashti F; Jin JY; Mutic S; El Naqa I; Siegel BA; Bradley JD
    J Nucl Med; 2006 Nov; 47(11):1808-12. PubMed ID: 17079814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
    Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
    J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.